1. Lee AJ, Wang JJ, Rochtchina E, et al. Patterns of glaucomatous visual field defects in an older population: the Blue Mountains Eye Study.
Clin Experiment Ophthalmol 2003;31:331-335.
2. Boden C, Hoffmann EM, Medeiros FA, et al. Intereye concordance in locations of visual field defects in primary open-angle glaucoma: diagnostic innovations in glaucoma study.
Ophthalmology 2006;113:918-923.
3. Chen PP, Bhandari A. Fellow eye prognosis in patients with severe visual field loss in 1 eye from chronic open-angle glaucoma.
Arch Ophthalmol 2000;118:473-478.
4. Chen PP. Correlation of visual field progression between eyes in patients with open-angle glaucoma.
Ophthalmology 2002;109:2093-2099.
5. Asman P, Heijl A. Glaucoma hemifield test: automated visual field evaluation.
Arch Ophthalmol 1992;110:812-819.
6. Ederer F, Gaasterland DE, Sullivan EK. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 1. Study design and methods and baseline characteristics of study patients.
Control Clin Trials 1994;15:299-325.
7. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 4. Comparison of treatment outcomes within race: seven-year results.
Ophthalmology 1998;105:1146-1164.
8. Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability?
Invest Ophthalmol Vis Sci 2000;41:2201-2204.
9. Caprioli J, Mock D, Bitrian E, et al. A method to measure and predict rates of regional visual field decay in glaucoma.
Invest Ophthalmol Vis Sci 2011;52:4765-4773.
10. Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons.
J Educ Behav Stat 2002;27:77-83.
11. Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2010.
12. Heijl A, Lindgren G, Olsson J, Asman P. Visual field interpretation with empiric probability maps.
Arch Ophthalmol 1989;107:204-208.
13. Heijl A, Leske MC, Bengtsson B, et al. Measuring visual field progression in the Early Manifest Glaucoma Trial.
Acta Ophthalmol Scand 2003;81:286-293.
14. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma.
Invest Ophthalmol Vis Sci 1996;37:1419-1428.
15. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Comparison of methods to detect visual field progression in glaucoma.
Ophthalmology 1997;104:1228-1236.
16. Nouri-Mahdavi K, Caprioli J, Coleman AL, et al. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.
Arch Ophthalmol 2005;123:193-199.
17. Katz J, Gilbert D, Quigley HA, Sommer A. Estimating progression of visual field loss in glaucoma.
Ophthalmology 1997;104:1017-1025.
18. Chauhan BC, Drance SM, Douglas GR. The use of visual field indices in detecting changes in the visual field in glaucoma.
Invest Ophthalmol Vis Sci 1990;31:512-520.
19. Wild JM, Hussey MK, Flanagan JG, Trope GE. Pointwise topographical and longitudinal modeling of the visual field in glaucoma.
Invest Ophthalmol Vis Sci 1993;34:1907-1916.
20. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields.
Am J Ophthalmol 1989;108:130-135.
21. Schulzer M. Errors in the diagnosis of visual field progression in normal-tension glaucoma.
Ophthalmology 1994;101:1589-1594.
22. Kim J, Dally LG, Ederer F, et al. The Advanced Glaucoma Intervention Study (AGIS). 14. Distinguishing progression of glaucoma from visual field fluctuations.
Ophthalmology 2004;111:2109-2116.
23. Wall M, Woodward KR, Doyle CK, Artes PH. Repeatability of automated perimetry: a comparison between standard automated perimetry with stimulus size III and V, matrix, and motion perimetry.
Invest Ophthalmol Vis Sci 2009;50:974-979.
24. Azarbod P, Mock D, Bitrian E, et al. Validation of pointwise exponential regression to measure the decay rates of glaucomatous visual fields.
Invest Ophthalmol Vis Sci 2012;53:5403-5409.
25. Spry PG, Sparrow JM, Diamond JP, Harris HS. Risk factors for progressive visual field loss in primary open angle glaucoma.
Eye 2005;19:643-651.
26. Pascual JP, Schiefer U, Paetzold J, et al. Spatial characteristics of visual field progression determined by Monte Carlo simulation: diagnostic innovations in glaucoma study.
Invest Ophthalmol Vis Sci 2007;48:1642-1650.
27. Boden C, Blumenthal EZ, Pascual J, et al. Patterns of glaucomatous visual field progression identified by three progression criteria.
Am J Ophthalmol 2004;138:1029-1036.
28. Mikelberg FS, Drance SM. The mode of progression of visual field defects in glaucoma.
Am J Ophthalmol 1984;98:443-445.